Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Covington
Fuji
Boehringer Ingelheim
Citi
Queensland Health
Harvard Business School

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,653,517

« Back to Dashboard

Summary for Patent: 5,653,517
Title: Process and system for determination of friction/slip characteristics of road vehicle tires
Abstract:For the determination of the friction/slip characteristics of the tires of a road vehicle which is equipped with an antilock system designed for an individual wheel control, in an initial phase of a controlled braking, only the wheel brake of an individual vehicle wheel is acted upon by brake pressure and the latter is dimensioned so that the result is the initial retardation in accordance with the driver's wish. During this initial test phase of the braking, the absolute brake slip .lambda..sub.B as well as the friction utilization .mu..sub.B linked therewith is continuously determined as soon as, as a result of just the braking of the test wheel, the vehicle retardation z increases no further and/or the braked vehicle wheel is more strongly retarded than corresponds to a predetermined threshold value, the test braking is interrupted and the braking is continued by pressure action on the further vehicle wheels; corresponding test braking phases are carried out in cyclic sequence for all guidance wheels.
Inventor(s): Burckhardt; Manfred (Waiblingen, DE), Eilert; Gerd (Schwaikheim, DE), Freitag; Rainer (Nuertingen, DE), Mueller; Armin (Backnang, DE), Schoeb; Reinhold (Filderstadt, DE), Spiecker; Rainer (Kernen, DE), Kazan; Sinan (Esslingen, DE), Zimmer; Richard (Fellbach, DE)
Assignee: Mercedes-Benz AG (DE)
Application Number:08/610,480
Patent Claim Types:
see list of patent claims
Process; Device;

Drugs Protected by US Patent 5,653,517

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,653,517

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany42 00 046.7Jan 3, 1992

International Patents Family Members for US Patent 5,653,517

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2594510 ➤ Try a Free Trial
Japan H07501772 ➤ Try a Free Trial
Japan 2554309 ➤ Try a Free Trial
Japan H07501771 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
UBS
Baxter
Julphar
US Army
Healthtrust
Federal Trade Commission
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.